
Join to View Full Profile
87 Grandview AveWaterbury, CT 06708
Phone+1 203-693-4973
Fax+1 484-273-4391
Dr. Wiraszka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Medical Branch Hospitals/Methodist Hospital (Houston)Residency, Ophthalmology, 2011 - 2014
Methodist Health System DallasInternship, Transitional Year, 2009 - 2010
University of Texas Southwestern Medical SchoolClass of 2009
The University of Texas at AustinB.S., Biology, Option: Molecular and Cell Biology, 2001 - 2004
Certifications & Licensure
GA State Medical License 2025 - 2027
SC State Medical License 2025 - 2027
TX State Medical License 2011 - 2027
CT State Medical License 2025 - 2026
MA State Medical License 2016 - 2026
ND State Medical License 2025 - 2026
PA State Medical License 2018 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HCIT Ophthalmology Suite Version 7.1, Health Care Intranet Technologies (HCIT), 2016-2017
- Academic High Performer Award University of Texas Medical Branch, Department of Ophthalmology and Visual Sciences, 2014
- Honors in Surgery University of Texas, Southwestern Medical Center, 2008
Publications & Presentations
PubMed
- 6 citationsCutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy.Vivian T. Yin, Tomasz A. Wiraszka, Michael T. Tetzlaff, Jonathan L. Curry, Bita Esmaeli
Ophthalmic Plastic and Reconstructive Surgery. 2015-07-20 - 7 citationsNicotine Exposure Exacerbates Development of Cataracts in a Type 1 Diabetic Rat ModelNima Tirgan, Gabriela A. Kulp, Praveena Gupta, Adam Boretsky, Tomasz A. Wiraszka
Experimental Diabetes Research. 2012-09-20 - 23 citationsInducible macropinocytosis of hyaluronan in B16-F10 melanoma cellsHenry J. Greyner, Tomasz Wiraszka, Li Shu Zhang, W. Matthew Petroll, Mark E. Mummert
Matrix Biology. 2010-07-01
Journal Articles
- Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib TherapyYin, V. T., Wiraszka, T. A., Tetzlaff, M., Curry, J. L., & Esmaeli, B, Ophthalmic plastic and reconstructive surgery, 1/1/2014
- Nicotine Exposure Exacerbates Development of Cataracts in a Type 1 Diabetic Rat ModelNima Tirgan, Gabriela A. Kulp, Praveena Gupta, Adam Boretsky, Tomasz Wiraszka, Bernard Godley, Ronald Tilton, Massoud Motamedi, Experimental Diabetes Research, 1/1/2012
- Divergence insufficiency: An Ongoing ChallengeWiraszka T, Gupta P, Review of Ophthalmology, 1/1/2012
Abstracts/Posters
- "Verucous Lesion" in Patient with Metastatic MelanomaWiraszka TA, Yin VT, Esmaeli B, Orbital Oncology and Oculofacial Surgery: Multidisciplinary Approach, MD Anderson Cancer Center, Houston, TX, 1/1/2013
- Nasopharyngeal carcinoma with bilateral ophthalmoplegiaWiraszka T, Orbital Oncology and Oculofacial Surgery: Multidisciplinary Approach, MD Anderson Cancer Center, Houston, TX, 1/1/2013
- Effect of Temperature, Light intensity and Molecular Size on Photokinetic Transscleral DrugTomasz Wiraszka, Gabriela Kulp, Edward Kraft, Aristides Koutrovelis, ARVO, 1/1/2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









